No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr20:22556800-22560800 |
Active TSS |
Pancreatic Islets |
Pancreatic Islet
|
2 |
chr20:22559200-22560600 |
Active TSS |
hESC Derived CD184+ Endoderm Cultured Cells |
ES cell derived
|
3 |
chr20:22559200-22562200 |
Weak transcription |
Gastric |
stomach
|
4 |
chr20:22559800-22560800 |
Bivalent Enhancer |
iPS-18 Cell Line |
embryonic stem cell
|
5 |
chr20:22560000-22560600 |
Bivalent/Poised TSS |
Rectal Mucosa Donor 31 |
rectum
|
6 |
chr20:22560000-22560800 |
Enhancers |
Liver |
Liver
|
7 |
chr20:22560000-22560800 |
Enhancers |
HepG2 |
liver
|
8 |
chr20:22560000-22561200 |
Bivalent Enhancer |
ES-UCSF4 Cell Line |
embryonic stem cell
|
9 |
chr20:22560200-22560600 |
Bivalent Enhancer |
hESC Derived CD56+ Ectoderm Cultured Cells |
ES cell derived
|
10 |
chr20:22560200-22561400 |
Genic enhancers |
A549 |
lung
|
11 |
chr20:22560400-22560600 |
Flanking Bivalent TSS/Enh |
H1 Cell Line |
embryonic stem cell
|
12 |
chr20:22560400-22560600 |
Bivalent Enhancer |
H9 Cell Line |
embryonic stem cell
|
13 |
chr20:22560400-22560600 |
Flanking Bivalent TSS/Enh |
HUES6 Cell Line |
embryonic stem cell
|
14 |
chr20:22560400-22560600 |
Flanking Bivalent TSS/Enh |
HUES64 Cell Line |
embryonic stem cell
|
15 |
chr20:22560400-22560600 |
Flanking Bivalent TSS/Enh |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
16 |
chr20:22560400-22560600 |
Flanking Active TSS |
Pancreas |
Pancrea
|
17 |
chr20:22560400-22560800 |
Bivalent Enhancer |
ES-WA7 Cell Line |
embryonic stem cell
|
18 |
chr20:22560400-22561000 |
Bivalent Enhancer |
Fetal Lung |
lung
|
19 |
chr20:22560400-22561000 |
Bivalent Enhancer |
Stomach Mucosa |
stomach
|
20 |
chr20:22560400-22561200 |
Flanking Bivalent TSS/Enh |
iPS-15b Cell Line |
embryonic stem cell
|
21 |
chr20:22560400-22561200 |
Bivalent Enhancer |
iPS DF 6.9 Cell Line |
embryonic stem cell
|